Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Paratek Pharmaceuticals Inc PRTK

Healthcare Industrials Business Services
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its commercial product, NUZYRA (omadacycline), is a once-daily oral and intravenous antibiotic for the treatment of adult... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PRTK)

Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023

GlobeNewswire October 5, 2023

Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.

GlobeNewswire September 21, 2023

Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S

GlobeNewswire September 18, 2023

Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S

GlobeNewswire September 12, 2023

Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings

GlobeNewswire September 7, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK

PR Newswire August 28, 2023

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital

PR Newswire August 22, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK

PR Newswire August 9, 2023

Investor Alert: Abbott Cooper PLLC Announces Investigation into Paratek Pharmaceuticals, Inc.; Urges Paratek Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

Business Wire August 9, 2023
View More News ››

Opinion & Analysis (NDAQ:PRTK)

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Streetwise Reports December 20, 2019

FDA Approves Biopharma's Drug with $1.75 Billion Peak Sales Potential

Streetwise Reports October 11, 2018
View More Opinion ››

Bullboard Posts (NDAQ:PRTK)

still watching & still waiting

for this stock to see which direction it goes,but the coming year will show the way,so glta.
coolfooldumbguy - December 31, 2019

watching this one for

a possible purchase,so glta.
coolfooldumbguy - December 19, 2019

RE: Upcoming FDA decision on the approval of a sma

Good to know .... I also hold a Jr Pharma named Pharmagap Inc.I&CloseCurlyQuote;m a shareholder trying to create greater...
bullorbear22 - July 5, 2009
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »